Former Illumina and Cisco Systems executive, Paula Dowdy, joins Quantum-Si’s Board of Directors, marking a significant development for the protein sequencing company. With over 35 years of experience spanning life sciences and technology, Dowdy’s expertise is poised to drive Quantum-Si’s growth and innovation. Her appointment reflects Quantum-Si’s commitment to revolutionizing protein sequencing for improved human health outcomes.